Re: Predictors of infectious complications after targeted prophylaxis for prostate needle biopsy

File Description SizeFormat 
Word of Wisdom - EU- HUA-24-03-2018.docxAccepted version156.06 kBMicrosoft WordView/Open
Title: Re: Predictors of infectious complications after targeted prophylaxis for prostate needle biopsy
Authors: Miah, S
Winkler, M
Ahmed, HU
Item Type: Journal Article
Abstract: Papagiannopoulos D, Abern M, Wilson N, et alJ Urol 2018;199:155–60Experts’ summary:Papagiannopoulos et al [1] are to be congratulated on their reporting of over 5000 men undergoing transrectal ultrasound-guided (TRUS) prostate biopsy with targeted antimicrobial prophylaxis with preprocedure rectal swab cultures. This method led to an overall infectious complication rate of 1.1%, whilst it was 3.9% for those harbouring a fluoroquinolone-resistant organism (odds ratio 9.98). Their article concluded that one should consider using alternative biopsy approaches to minimise infectious complications in this higher-risk cohort who harbour fluoroquinolone resistance.
Issue Date: 1-Oct-2018
Date of Acceptance: 7-Apr-2018
ISSN: 0302-2838
Publisher: Elsevier
Start Page: 523
End Page: 524
Journal / Book Title: European Urology
Volume: 74
Issue: 4
Copyright Statement: © 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Sponsor/Funder: Wellcome Trust
University College London Hospitals Charity
Funder's Grant Number: 204998/Z/16/Z
Keywords: Science & Technology
Life Sciences & Biomedicine
Urology & Nephrology
1103 Clinical Sciences
Publication Status: Published
Conference Place: Switzerland
Online Publication Date: 2018-04-22
Appears in Collections:Division of Surgery
Faculty of Medicine

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commonsx